176 related articles for article (PubMed ID: 36007784)
1. Intercellular communication in the tumour microecosystem: Mediators and therapeutic approaches for hepatocellular carcinoma.
Wang WT; Jin WL; Li X
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166528. PubMed ID: 36007784
[TBL] [Abstract][Full Text] [Related]
2. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
3. [Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment].
Feng T; Yang X; Wang Q; Liu X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):6-12. PubMed ID: 38322525
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
Wu MN; Sun JY; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
[TBL] [Abstract][Full Text] [Related]
6. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
[TBL] [Abstract][Full Text] [Related]
7. Exosomes: small vesicles with big roles in hepatocellular carcinoma.
Wu Z; Zeng Q; Cao K; Sun Y
Oncotarget; 2016 Sep; 7(37):60687-60697. PubMed ID: 27463001
[TBL] [Abstract][Full Text] [Related]
8. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value.
He R; Wang Z; Shi W; Yu L; Xia H; Huang Z; Liu S; Zhao X; Xu Y; Yam JWP; Cui Y
Biomed Pharmacother; 2021 Jun; 138():111529. PubMed ID: 34311529
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in the emerging role of exosome in hepatocellular carcinoma.
Abudoureyimu M; Zhou H; Zhi Y; Wang T; Feng B; Wang R; Chu X
Cell Prolif; 2019 Mar; 52(2):e12541. PubMed ID: 30397975
[TBL] [Abstract][Full Text] [Related]
11. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
Wu Q; Zhou L; Lv D; Zhu X; Tang H
J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
[TBL] [Abstract][Full Text] [Related]
14. Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?
Li S; Dong R; Kang Z; Li H; Wu X; Li T
Cytokine Growth Factor Rev; 2023 Oct; 73():93-100. PubMed ID: 37541791
[TBL] [Abstract][Full Text] [Related]
15. Role of exosomes in treatment of hepatocellular carcinoma.
Moris D; Beal EW; Chakedis J; Burkhart RA; Schmidt C; Dillhoff M; Zhang X; Theocharis S; Pawlik TM
Surg Oncol; 2017 Sep; 26(3):219-228. PubMed ID: 28807240
[TBL] [Abstract][Full Text] [Related]
16. Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review).
Yang S; Wang J; Wang S; Zhou A; Zhao G; Li P
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674180
[TBL] [Abstract][Full Text] [Related]
17. Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma.
Yeung CLS; Yam JWP
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1088-1101. PubMed ID: 35158067
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Mo Z; Liu D; Rong D; Zhang S
Front Immunol; 2021; 12():611058. PubMed ID: 33679749
[No Abstract] [Full Text] [Related]
19. Fibronectin 1 derived from tumor-associated macrophages and fibroblasts promotes metastasis through the JUN pathway in hepatocellular carcinoma.
Zhang L; Zhang C; Xing Z; Lou C; Fang J; Wang Z; Li M; He H; Bai H
Int Immunopharmacol; 2022 Dec; 113(Pt A):109420. PubMed ID: 36461607
[TBL] [Abstract][Full Text] [Related]
20. Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma.
Jamshidi-Parsian A; Griffin RJ; Kore RA; Todorova VK; Makhoul I
Exp Cell Res; 2018 Nov; 372(1):16-24. PubMed ID: 30205087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
